A motor protein called myosin II was identified in a recent study to be a driver of fibrosis development — a finding with…
Magdalena Kegel
Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Magdalena Kegel
A European survey of patients with idiopathic pulmonary fibrosis (IPF) found that patients well understand the disease’s significant physical and emotional impact on their quality…
A new article that reviews available treatment options for idiopathic pulmonary fibrosis (IPF) took a critical but positive look at available…
Researchers from a large number of international institutions have published an integrated analysis showing that long-term treatment with pirfenidone…
A new study from the Children’s Hospital of Chongqing Medical University, China, reports that the drug fasudil helps to prevent lung fibrosis development…
A potentially important new study, published in the Journal of Biological Chemistry, identified fibroblast activation protein (FAP) as…